Announced its interim consolidated financial results for the quarter ended September 30, 2025. WELL achieved record quarterly revenues of $364.6 million in Q3-2025, an increase of 56% compared to Q3-2024 driven by organic growth and acquisitions. WELL achieved record Adjusted EBITDA of $59.9 million in Q3-2025, an increase of 296% compared to $15.1 million in Q3-2024, representing Adjusted EBITDA margin of 16.4%. WELL Health Technologies Corp. shares T.WELL are trading up $0.03 at $4.93.
Stocks in play: WELL Health Technologies Corp.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/Broadcom%20Inc%20logo%20on%20building-by%20Poetra_%20RH%20via%20Shutterstock.jpg)
/AI%20(artificial%20intelligence)/Data%20Center%20by%20Caureem%20via%20Shutterstock%20(2).jpg)
/Nvidia%20logo%20on%20phone%20screen%20with%20stock%20chart%20by%20xalien%20via%20Shutterstock.jpg)